Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 20,655 | 23,230 | 22,443 | 20,018 | 20,605 |
| Cost of Goods | 10,941 | 11,351 | 14,522 | 9,207 | 9,392 |
| Gross Profit | 9,714 | 11,879 | 7,921 | 10,811 | 11,213 |
| Operating Expenses | 64,192 | 63,938 | 68,912 | 63,132 | 72,901 |
| Operating Income | -53,537 | -51,708 | -60,469 | -52,114 | -61,296 |
| Other Income | -1,109 | -700 | -546 | -500 | -985 |
| Pre-tax Income | -54,646 | -52,408 | -61,015 | -52,614 | -62,281 |
| Net Income Continuous | -54,646 | -52,408 | -61,015 | -52,614 | -62,281 |
| Net Income | $-54,646 | $-52,408 | $-61,015 | $-52,614 | $-62,281 |
| EPS Basic Total Ops | -0.53 | -0.51 | -0.62 | -0.58 | -0.68 |
| EPS Basic Continuous Ops | -0.53 | -0.51 | -0.62 | -0.58 | -0.68 |
| EPS Diluted Total Ops | -0.53 | -0.51 | -0.62 | -0.58 | -0.68 |
| EPS Diluted Continuous Ops | -0.53 | -0.51 | -0.62 | -0.58 | -0.68 |
| EBITDA(a) | $-52,584 | $-50,840 | $-59,322 | $-50,825 | $-60,082 |